Curtis Michael J, Alexander Steve, Cirino Giuseppe, Docherty James R, George Christopher H, Giembycz Mark A, Hoyer Daniel, Insel Paul A, Izzo Angelo A, Ji Yong, MacEwan David J, Sobey Christopher G, Stanford S Clare, Teixeira Mauro M, Wonnacott Sue, Ahluwalia Amrita
Kings College London, London, UK.
University of Nottingham, Nottingham, UK.
Br J Pharmacol. 2018 Apr;175(7):987-993. doi: 10.1111/bph.14153.
This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.
本文更新了2015年发布的针对向《英国药理学杂志》投稿作者的指南（柯蒂斯等人，2015年），旨在为同行评审提供准则。因此，它面向作者、评审人员和编辑。许多要求的解释先前已概述，此处不再重述。新指南旨在取代先前发布的指南。为便于作者理解，指南已简化，以使同行评审人员更直接地检查合规情况，并促进期刊提高标准工作的管理。
